UnknownNot Applicable

Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops

South Korea2,000 participantsStarted 2023-02-08

Plain-language summary

This study is to verify the efficacy and safety in the treatment of dry eye syndrome in patients prescribed with Diquasol eye drops as a monotherapy, or in combination with Hyaluron eye drops, or in combination with Hyaluronmax eye drops.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 19 years and older * Patients with dry eye syndrome with TBUT of 10 or less * Individuals scheduled to receive either Diquasol eye drops as a monotherapy or a combination therapy of Diquasol eye drops with Hyaluron eye drops or Diquasol eye drops with Hyaluronmax eye drops, based on clinical judgment for the treatment of dry eye syndrome * Individuals who have voluntarily provided written consent for participation in this study Exclusion Criteria: * Pregnant or lactating women * Individuals contraindicated according to the approval conditions of Diquasol eye drops, Hyaluron eye drops, and Hyaluronmax eye drops * Cases where the principal investigator or study personnel deem the individual unsuitable for participation in this clinical study

What they're measuring

Primary Assessment Variables

Timeframe: after 12 weeks of prescription for Diquasol eye drops and Hyaluron/Hyaluronmax eye drops compared to baseline

Trial details

NCT IDNCT06172530

SponsorHanlim Pharm. Co., Ltd.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-05

Contact for this trial

Sol Jo

+82-2-3489-6299 ssoljo@hanlim.com

View on ClinicalTrials.gov More Dry Eye Syndrome trials